Investing NewsCytokinetics Stock Skyrockets on Positive Results from Study of Its Heart DrugDecember 27, 2023 by admin 0 Comments Cytokinetics Inc. reported positive results Wednesday from a key Phase 3 study of its experimental drug to treat heart disease. Articles You May Like All In: Daniel Loeb Put 37% of Portfolio in These 3 Stocks. Masterstroke or Misstep? Stock Market Crash Warning: Don’t Get Caught Holding These 3 Robotics Stocks The Unshakeable Seven: Bet On These Consumer Defensive Stocks to Navigate Market Mayhem 3 Retail Stocks Most at Risk of the New Cautious Consumer Trend Why is Accumulated Depreciation a Credit Balance?